DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Paragard T380a (Copper Intrauterine) - Published Studies

 
 



Paragard T380a Related Published Studies

Well-designed clinical trials related to Paragard T380a (Copper Intrauterine)

Timing of copper intrauterine device insertion after medical abortion: a randomized controlled trial. [2011.09]

Immediate vs. delayed post-abortal copper T 380A IUD insertion in cases over 12 weeks of gestation. [2011.06]

Copper containing intra-uterine devices versus depot progestogens for contraception. [2010.06.16]

Intrauterine contraception for adolescents aged 14-18 years: a multicenter randomized pilot study of levonorgestrel-releasing intrauterine system compared to the Copper T 380A. [2010.02]

The frameless copper IUD (GyneFix) and the TCu380A IUD: results of an 8-year multicenter randomized comparative trial. [2009.08]

Comparative study on contraceptive efficacy and clinical performance of the copper/low-density polyethylene nanocomposite IUD and the copper T220C IUD. [2008.10]

Copper-containing, framed intrauterine devices for contraception: a systematic review of randomized controlled trials. [2008.05]

A randomized trial on the clinical performance of Nova T380 and Gyne T380 Slimline copper IUDs. [2007.03]

Pain from copper intrauterine device insertion: randomized trial of prophylactic ibuprofen. [2006.11]

Preventing copper intrauterine device removals due to side effects among first-time users: randomized trial to study the effect of prophylactic ibuprofen. [2006.06]

A comparative study of the levonorgestrel-releasing intrauterine system Mirena(R) versus the Copper T380A intrauterine device during lactation: breast-feeding performance, infant growth and infant development. [2005.11]

Randomized assignment to copper IUD or depot-medroxyprogesterone acetate: feasibility of enrollment, continuation and disease ascertainment. [2005.09]

Effectiveness and mechanism of action of desmopressin in the treatment of copper intrauterine device-related menorrhagia: a pilot study. [2003.11]

Randomized comparison of levonorgestrel- and copper-releasing intrauterine systems immediately after abortion, with 5 years' follow-up. [2003.07]

The effect of low-dose 3-keto-desogestrel added to a copper-releasing intrauterine contraceptive device on menstrual blood loss: a double-blind, dose-finding, placebo-controlled study. [2000.03]

How effectively do copper intrauterine devices prevent ectopic pregnancy? [1997.08]

Detailed analysis of menstrual bleeding patterns after postmenstrual and postabortal insertion of a copper IUD or a levonorgestrel-releasing intrauterine system. [1996.10]

A comparative study of two techniques used in immediate postplacental insertion (IPPI) of the Copper T-380A IUD in Shanghai, People's Republic of China. [1996.07]

An evaluation of the copper-T 380A IUD's safety and efficacy at three African centers. [1996.05]

Performances of copper T 380A and multiload copper 375/250 intrauterine contraceptive devices in a comparative clinical trial. [1995.03]

Contraceptive efficacy of the Copper T380A and the Multiload Cu250 IUD in three developing countries. [1994.06]

Menstrual bleeding pattern and iron status in women fitted with copper and non-medicated intrauterine contraceptive devices. [1994.04]

Contraceptive efficacy of the Copper T 380A and Copper T 200 intrauterine devices: results from a comparative clinical trial in six developing countries. [1994.03]

Health during prolonged use of levonorgestrel 20 micrograms/d and the copper TCu 380Ag intrauterine contraceptive devices: a multicenter study. International Committee for Contraception Research (ICCR). [1994.01]

Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial. [1994.01]

Active oxygen species in copper intrauterine device users. [1993.08]

Factors associated with copper T IUD removal for bleeding/pain: a multivariate analysis. [1993.07]

Four-year experience in a randomized study of the Gyne T 380 Slimline and the Standard Gyne T 380 intrauterine copper devices. [1993.01]

Prolonged intrauterine contraception: a seven-year randomized study of the levonorgestrel 20 mcg/day (LNg 20) and the Copper T380 Ag IUDS. [1991.11]

Serum lipid variations in women on copper intrauterine devices, triphasic oral contraceptives and monthly injectable contraceptives. [1991.09]

The effect of adding copper onto Lippes Loop IUDs: results from a ten-year study in Yugoslavia. [1991.03]

Protective effect of intrauterine release of levonorgestrel on pelvic infection: three years' comparative experience of levonorgestrel- and copper-releasing intrauterine devices. [1991.02]

Long-term contraception with the levonorgestrel 20 mcg/day (LNg 20) and the copper T 380Ag intrauterine devices: a five-year randomized study. [1990.10]

Well-designed clinical trials possibly related to Paragard T380a (Copper Intrauterine)

Vaginal misoprostol prior to insertion of an intrauterine device: an RCT. [2011.02]

The effect of patient gynecologic history on clinician contraceptive counseling. [2010.09]

Immediate postabortal insertion of intrauterine devices. [2010.06.16]

Reaching providers is not enough to increase iud use: a factorial experiment of 'academic detailing' in kenya. [2008.01]

Cervical priming with sublingual misoprostol prior to insertion of an intrauterine device in nulliparous women: a randomized controlled trial. [2007.10]

A randomized trial of the intrauterine contraceptive device vs hormonal contraception in women who are infected with the human immunodeficiency virus. [2007.08]

Use of IUD and subsequent fertility - follow-up after participation in a randomized clinical trial. [2007.02]

[Random comparative study between intrauterine device Multiload Cu375 and TCu 380a inserted in the postpartum period] [2006.06]

Contraception in perimenopausal women with diabetes mellitus. [2006.04]

A trial of contraceptive methods in women with systemic lupus erythematosus. [2005.12.15]

Effect of a levonorgestrel intrauterine system on women with type 1 diabetes: a randomized trial. [2005.04]

Immediate postabortal insertion of intrauterine devices. [2004.10.18]

Microbial and cytopathological study of intrauterine contraceptive device users. [2004.09]

[A multicentre comparative clinical study of uterine cavity shaped device Cu300, TCu220C and TCu380A in ten years] [2003.05]

Comparative trial of the force required for, and pain of, removing GyneFix versus Gyne-T380S following randomised insertion. [2003.04]

A comparative randomized study of three different IUDs in nulliparous Mexican women. [2003.04]

The effect on intrauterine device position and performance of a modified TCu380A insertion technique. [2002.03]

Immediate postabortal insertion of intrauterine devices. [2002]

Randomized comparative trial in parous women of the frameless GyneFix and the TCu380A intrauterine devices: long-term experience in a Chinese family planning clinic. [2000.06]

Performance of the frameless GyneFix and the TCu380A IUDs in a 3-year multicenter, randomized, comparative trial in parous women. [2000.02]

Immediate post-abortal insertion of intrauterine devices. [2000]

Analysis of client characteristics that may affect early discontinuation of the TCu-380A IUD. [1999.09]

Health effects of long-term use of the intrauterine levonorgestrel-releasing system. A follow-up study over 12 years of continuous use. [1999.09]

Feeding strategies for premature infants: beneficial outcomes of feeding fortified human milk versus preterm formula. [1999.06]

The effect of intrauterine and oral levonorgestrel administration on serum concentrations of sex hormone-binding globulin, insulin and insulin-like growth factor binding protein-1. [1999.05]

Endometrial histology in long-term users of the once-a-month injectable contraceptive Cyclofem. [1999]

Performance of the frameless IUD (Flexigard prototype inserter) and the TCu380A after six years as part of a WHO multicenter randomized comparative clinical trial in parous women. [1999]

Can intrauterine device removals for bleeding or pain be predicted at a one-month follow-up visit? A multivariate analysis. [1998.12]

[Prophylactic use of prostaglandin synthesis inhibitors in connection with IUD insertion] [1998.11.23]

Twelve-month comparative multicenter study of the TCu 380A and ML 250 intrauterine devices in Bangkok, Thailand. [1998.10]

[Randomized comparative study of GyneFix IN and TCu 380A intrauterine devices] [1998.06]

Randomised controlled trial of prophylactic antibiotics before insertion of intrauterine devices. IUD Study Group. [1998.04.04]

Non-physician insertion of IUDs: clinical outcomes among TCu380A insertions in three developing-country clinics. [1998.03]

Nutrient accretion in preterm infants fed formula with different protein:energy ratios. [1997.07]

[Comparison of two techniques used in immediate postplacental insertion of TCu 380A intrauterine device: 12 month follow-up of 910 cases] [1997.06]

[Medicated stainless steel ring-165, medicated gamma-intrauterine devices and TCu220C: a multicenter comparative study] [1997.02]

Immediate postplacental insertion of GYNE-T 380 and GYNE-T 380 postpartum intrauterine contraceptive devices: randomized study. [1996.11]

Performance of the TCu380A and Cu-Fix IUDs in an international randomized trail. [1996.04]

Comparative study of safety and efficacy of IUD insertions by physicians and nursing personnel in Brazil. [1995.09]

Clinical performance of the TCu 380A and Lippes Loop IUDs in three developing countries. [1995.07]

Effects of a progestogen-only pill (Exluton) and an intrauterine device (Multiload Cu250) on breastfeeding. [1995.06]

A randomized comparative study of the TCu380A and Cu-Safe 300 IUDs. [1995.06]

Clinical performance of the TCu 380A and TCu 220C IUDs in four developing country family planning clinics. [1994.11]

[Multiload Cu250 intrauterine devices and VCu200 intrauterine devices for women with previous failure of stainless steel ring intrauterine devices: a 5-year randomized clinical trial] [1994.08]

Clinical evaluation of the TCu 380A IUD at six Latin American centers. [1994.07]

The presence of mast cells in the human endometrium pre- and post-insertion of intrauterine devices. [1993.09]

Another look at the Dalkon Shield: meta-analysis underscores its problems. [1993.07]

A Latin American experience with levonorgestrel IUD. [1993.04]

Return to fertility after removal of a levonorgestrel-releasing intrauterine device and Nova-T. [1992.12]

Randomised comparative study in 217 women of three disposable plastic IUCD thread retrievers. [1992.11]

Comparison of two uterine cavity-shaped IUDs. [1992.09]

A randomized comparative trial of the MLCu375, TCu220C, steel ring and uterine cavity-shaped IUDs. [1992.06]

A New Zealand randomized comparative study of three IUDs (Nova-T, MLCu375, MLAgCu250): 1-, 2- and 3-year results. [1992.06]

Observation of the activity of factor VIII in the endometrium of women pre- and post-insertion of three types of IUDs. [1991.10]

A comparative clinical trial of the TCu 380A, Lippes Loop D and Multiload Cu 375 IUDs in Indonesia. [1991.08]

Clinical performance of intrauterine devices in nulligravidae: is the length of the endometrial cavity of significance? [1991.07]

IUDs and PID: a comparative trial of strings versus stringless devices. [1991.06]

Effects of various IUDs on the composition of cervical mucus. [1991.05]

Other research related to Paragard T380a (Copper Intrauterine)

Contraceptive adherence among HIV-infected women in Malawi: a randomized controlled trial of the copper intrauterine device and depot medroxyprogesterone acetate. [2013]

Levonorgestrel-releasing and copper intrauterine devices and the risk of breast cancer. [2011.03]

Timing of copper intrauterine device insertion after medical abortion: a randomized controlled trial. [2011]

A pilot study of the Copper T380A IUD and oral levonorgestrel for emergency contraception. [2010.12]

Copper T380A intrauterine device for emergency contraception: a prospective, multicentre, cohort clinical trial. [2010.09]

Does over-exposure to copper ions released from metallic copper induce cytotoxic and genotoxic effects on mammalian cells? [2010.04]

Alterations in copper homeostasis and oxidative stress biomarkers in women using the intrauterine device TCu380A. [2010.02.15]

Intrauterine contraception for adolescents aged 14-18 years: a multicenter randomized pilot study of levonorgestrel-releasing intrauterine system compared to the Copper T 380A. [2010]

The effects of copper contraceptive intrauterine device on the uterine blood flow: A prospective transvaginal Doppler study. [2009.09]

Study on a novel copper-containing composite for contraception. [2009.06]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017